Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring
- 1 October 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 122 (4), 800-808
- https://doi.org/10.1097/aog.0b013e3182a5ec6b
Abstract
To compare the risks of short-term and long-term use of an etonogestrel-containing and ethinylestradiol-containing vaginal ring and combined oral contraceptive pills (OCPs) in a routine clinical study population. This was a prospective, controlled, noninterventional cohort study performed in the United States and five European countries with the following two cohorts: new users of the vaginal ring and new users of combined OCPs (starters, switchers, or restarters). The study population included 33,295 users of the vaginal ring or combined OCPs recruited by 1,661 study centers. Follow-up of study participants occurred for 2 to 4 years. Main clinical outcomes of interest were cardiovascular outcomes, particularly venous and arterial thromboembolism. These outcomes were validated by attending physicians and further adjudicated by an independent board. Comprehensive follow-up ensured low loss to follow-up. Statistical analyses were based on Cox regression models. Primary statistical variable was the venous thromboembolic hazard ratio (HR) for the vaginal ring compared with combined OCPs. Study participants were followed-up for 66,489 woman-years. Loss to follow-up was 2.9%. The venous thromboembolism incidence rates for the vaginal ring users and combined OCPs users were 8.3 and 9.2 per 10,000 woman-years, respectively. Cox regression analysis yielded crude and adjusted HRs for the vaginal ring users compared with combined OCPs users of 0.9 and 0.8 for venous thromboembolism (95% confidence intervals [CIs] 0.5-1.6 and 0.5-1.5) and 0.8 and 0.7 (95% CIs 0.2-2.5 and 0.2-2.3) for arterial thromboembolism, respectively. Vaginal ring use and combined OCP use were associated with a similar venous and arterial thromboembolic risk during routine clinical use. : II.Keywords
This publication has 23 references indexed in Scilit:
- Epidemiologic Research Using Administrative Databases: Garbage In, Garbage OutObstetrics & Gynecology, 2011
- Hormonal contraception and risk of venous thromboembolism: national follow-up studyBMJ, 2009
- Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 3: Principles of causality in epidemiological research: statistical stability, dose- and duration-response effects, internal and external consistency, analogy and biological plausibilityBMJ Sexual & Reproductive Health, 2008
- Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy Part 2. Principles of causality in epidemiological research: confounding, effect modification and strength of associationBMJ Sexual & Reproductive Health, 2008
- The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observationContraception, 2007
- Bias in the evaluation of low-magnitude associations: an empirical perspective.American Journal of Epidemiology, 2000
- Epidemiology Faces Its LimitsScience, 1995
- Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogensTeratology, 1992
- What is a Cause and How Do We Know One? A Grammar for Pragmatic EpidemiologyAmerican Journal of Epidemiology, 1991
- A Strengthening Programme for Weak AssociationsInternational Journal of Epidemiology, 1988